Skip to main content
. Author manuscript; available in PMC: 2024 Oct 9.
Published in final edited form as: J Allergy Clin Immunol. 2024 Apr 8;153(6):1621–1633. doi: 10.1016/j.jaci.2024.02.019

TABLE I.

Characteristics of 36 members of expert panel

Characteristic No. (%) or median [IQR]
Practice type
 Academic 20 (55.6)
 Private practice 9 (25.0)
 Mixed/both 7 (19.4)
Patient profile
 Child 21 (58.3)
 Adult 0
 Mixed/both 15 (41.7)
Years in practice 15.0 [10.0, 25.0]
Have you published peer-reviewed articles on OIT?
 Yes 36 (100)
Do you perform OIT in your practice?
 Yes 34 (94.4)
How many years have you performed OIT? 10.0 [7.0, 12.0]
Please estimate the number of patients you have managed with OIT. 400.0 [150.0, 800.0]
What allergens do you perform OIT for?
 Peanut 34 (94.4)
 Tree nuts 28 (77.8)
 Milk 31 (86.1)
 Egg 30 (83.3)
 Sesame 24 (66.7)
 Wheat 25 (69.4)
 Other 14 (38.9)
In what context do you perform OIT?
 Clinical practice 15 (44.1)
 Clinical trial 2 (5.9)
 Both 17 (50.0)
Do you obtain written informed consent before initiating OIT?
 Yes 32 (94.1)
How long (minutes) on average do you estimate you spend obtaining informed consent for OIT? 30.0 [20.0, 60.0]
Who performs OIT consent discussion at your center?
 Attending physician 30 (83.3)
 Resident or fellow (physician in training) 7 (19.4)
 Physician assistant 7 (19.4)
 Nurse practitioner 7 (19.4)
 Nurse 9 (25.0)
 Other 3 (8.3)
How is OIT funded at your center?
 Public insurance 15 (41.7)
 Private insurance 18 (50.0)
 Direct payment (out of pocket) 13 (36.1)
 Clinical trial 14 (38.9)
 Other 3 (8.3)